A detailed history of Lord, Abbett & Co. LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 782,354 shares of MIRM stock, worth $33.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
782,354
Previous 741,368 5.53%
Holding current value
$33.6 Million
Previous $28.9 Million 11.89%
% of portfolio
0.1%
Previous 0.09%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$37.85 - $46.65 $1.55 Million - $1.91 Million
40,986 Added 5.53%
782,354 $32.4 Million
Q3 2024

Nov 14, 2024

BUY
$33.68 - $44.74 $25 Million - $33.2 Million
741,368 New
741,368 $28.9 Million

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.58B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Lord, Abbett & Co. LLC Portfolio

Follow Lord, Abbett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.